Eric Mark Horwitz
Fox Chase Cancer Center · 457 works · 20,039 citations · h-index 69
Top works
- Prostate Cancer
- Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology
- Phase III Trial of Long-Term Adjuvant Androgen Deprivation After Neoadjuvant Hormonal Cytoreduction and Radiotherapy in Locally Advanced Carcinoma of the Prostate: The Radiation Therapy Oncology Group Protocol 92–02
- A War on Two Fronts: Cancer Care in the Time of COVID-19
- Ten-Year Follow-Up of Radiation Therapy Oncology Group Protocol 92-02: A Phase III Trial of the Duration of Elective Androgen Deprivation in Locally Advanced Prostate Cancer
- Adaptive modification of treatment planning to minimize the deleterious effects of treatment setup errors
- Comparison of alternative biochemical failure definitions based on clinical outcome in 4839 prostate cancer patients treated by external beam radiotherapy between 1986 and 1995
- Prostate Cancer, Version 1.2016
- Intermittent Androgen Suppression for Rising PSA Level after Radiotherapy
- Dose selection for prostate cancer patients based on dose comparison and dose response studies
- Long-term multi-institutional analysis of stage T1–T2 prostate cancer treated with radiotherapy in the PSA era
- Multi-institutional analysis of long-term outcome for stages T1–T2 prostate cancer treated with permanent seed implantation
- Randomized Trial of Hypofractionated External-Beam Radiotherapy for Prostate Cancer
- A clinical evaluation of a novel liposomal carrier for acyclovir in the topical treatment of recurrent herpes labialis
- Dose response in prostate cancer with 8–12 years’ follow-up
- Prostate Cancer, Version 2.2014
- Prostate Cancer Radiotherapy Dose Response: An Update of the Fox Chase Experience
- NCCN Guidelines Insights: Prostate Cancer, Version 1.2021
- Phase II Study of Low-Dose Paclitaxel and Cisplatin in Combination With Split-Course Concomitant Twice-Daily Reirradiation in Recurrent Squamous Cell Carcinoma of the Head and Neck: Results of Radiation Therapy Oncology Group Protocol 9911
- Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, Part I: Introduction, Risk Assessment, Staging, and Risk-Based Management